The Mission Was Always For Sale

Mission brands always end up owned by the enemy

In March 2026, Danone acquired Huel for roughly €1 billion.

Huel spent a decade positioning itself as an antidote to junk food. That mission ran through every ad, every product page, every founder interview. Customers believed they were buying into something that stood against the broken food system.

Now it belongs to the company behind Actimel.

A year earlier, Unilever acquired Wild for around £230 million. Wild built its brand on eliminating single-use plastic. Its founders talked about sustainability with what looked like genuine conviction. The enemy was faceless corporations pumping out billions of plastic containers.

Turns out Unilever produces more single-use plastic than almost any personal care company on earth. And recently scaled back its own sustainability targets.

This keeps happening. It should have a name by now.

Innocent Drinks spent a decade as the anti-corporate smoothie brand, then sold to Coca-Cola. Green & Black’s, the ethical chocolate, sold to Cadbury and got absorbed by Kraft. The Body Shop sold to L’Oréal. Ben & Jerry’s sold to Unilever in 2000, and 25 years later co-founder Ben Cohen is publicly trying to buy it back because the mission he was promised would be protected has been systematically taken apart.

Every one of these brands was built on the same premise: we’re the alternative. Every one ended up inside the thing they were the alternative to.

The betrayal is structural

Most founders genuinely believe in what they’re building. Conviction is real - you don’t survive years of rejection on cynicism alone.

But to fight giants, you need resources. To get resources, you need investors. And from the moment that first cheque clears, you have two missions: the thing you said you were building, and the financial outcome you’ve implicitly promised to deliver.

Investors have timelines. They expect returns. For a while, both missions coexist - the mission attracts customers, customers drive growth, growth attracts more investment. Then you reach the top metrics. Investors want their return. You can keep growing independently - slow, uncertain. Or you can sell to exactly the kind of company your brand was built against, and deliver a clean, enormous payday for everyone at the table.

The founder doesn’t wake up and decide to betray the mission. The structure they entered was always going to lead here.

The script never changes

Every acquisition announcement reads the same way.

Huel’s statement said the deal lets them “grow faster, reach more people, and keep improving products.” Wild’s co-founder said Unilever’s reach would “accelerate our mission.” Innocent’s founders said Coca-Cola would help them get smoothies “to more people in more places.”

Scale-up. Never sellout. Every time.

I think founders are dishonest with themselves in these moments, not just with the public. And maybe that self-deception is part of the wiring that makes entrepreneurship possible in the first place - the same quality that lets you ignore everyone telling you your idea won’t work is the same quality that lets you rationalise handing your mission to the highest bidder.

The darkest part: Most consumers keep buying

When you buy a Wild deodorant or mix your Huel shake every morning, you’re buying a story about yourself. You’re the person who cares. You’re making the better choice.

Then one morning you find out Unilever owns it. There’s a flash of discomfort. But the habit is already formed. The product is already in your routine. It still feels like the better choice, even though the company behind it is the one you thought you were rejecting.

These brands sell the feeling of change. Old habits replaced with new habits that feel better but sit inside the same system. Moral self-medication. And the medication still works after the acquisition, because the feeling was always the product.

The mission outlives its own authenticity.

The ones who actually meant it

In 2022, Yvon Chouinard transferred his family’s entire ownership of Patagonia, valued at $3 billion, to a purpose trust and a nonprofit. All future profits go to fighting climate change. No payday. He considered selling. He considered an IPO. He concluded both paths would erode everything Patagonia stood for. So he removed the possibility entirely.

Dr. Bronner’s has been family-owned since 1948. No outside investors. The company caps executive pay at five times its lowest-paid employee and donates all profits beyond what it needs to operate. In 2025, it dropped its B Corp certification — not because the company had changed, but because B Lab started certifying Unilever and Nestlé, and Dr. Bronner’s refused to share a label being used for greenwashing.

They walked away from a credential most brands chase because it no longer meant what it was supposed to mean.

Both companies prove the same point: the choice exists. But notice what Patagonia and Dr. Bronner’s have in common. No venture capital. No investors demanding a return. No cap table dictating the ending.

If you take the VC money, you’ve already made the choice. The rest is just timing.

The real question

Turning down a billion-dollar offer requires a kind of conviction almost none of us will ever be tested on.

If your goal is to build a company, make money, and exit - brilliant. Congratulations. That’s a hard thing to pull off and worth celebrating. And I’m all in.

The uncomfortable part is this: being upfront about it would kill the brand before it starts. Nobody rallies behind “I want to build something great and if the right offer comes I’ll probably take it.” Nobody pays a premium for radical commercial honesty.

The system requires the performance of mission to function.

The next time a founder tells you they’re on a mission to change the world, ask one question: who owns your cap table?

The answer will tell you how the story ends.